Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Certain gene variations might be linked to severe acne in women but not in men.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Taurine and apocynin together improve burn healing, especially later in recovery.

Apremilast showed mixed results for treating severe alopecia areata.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Squaric acid dibutylester effectively treats alopecia areata.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Tofacitinib treatment is used for teenagers with alopecia areata.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

A man developed hair loss from testosterone treatment but improved with additional medication.

Stopping aripiprazole can reverse its side effect of hair loss.

Targeting CXCL10 may help treat alopecia areata.

Impaired autophagy may contribute to alopecia areata.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.